Summary

Eligibility
for people ages 3-18 (full criteria)
Location
at San Diego, California and other locations
Dates
study started
completion around
Principal Investigator
by Kathryn Akong, MD

Description

Summary

The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.

Official Title

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Randomized Controlled Trial (STOP PEDS RCT)

Details

Keywords

Cystic Fibrosis, oral antibiotics, pulmonary exacerbation, pediatric, Fibrosis, Anti-Bacterial Agents, Antitubercular Antibiotics, Immediate Oral Antibiotics, Tailored Treatment: Oral Antibiotics only if Additional Treatment needed, Immediate Antibiotics, Tailored Therapy

Eligibility

Locations

  • Rady Children's Hospital at University of California San Diego not yet accepting patients
    San Diego California 92123 United States
  • Children's Hospital of Los Angeles & Anton Yelchin Cystic Fibrosis Clinic not yet accepting patients
    Los Angeles California 90027 United States
  • Children's Hospital of Colorado accepting new patients
    Aurora Colorado 80045 United States
  • Riley Hospital for Children & Indiana University accepting new patients
    Indianapolis Indiana 46202 United States

Lead Scientist at UCSD

  • Kathryn Akong, MD
    Clinical Professor, Pediatrics, Vc-health Sciences-schools. Authored (or co-authored) 14 research publications

Details

Status
accepting new patients at some sites,
but this study is not currently recruiting here
Start Date
Completion Date
(estimated)
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center
Links
STOP PEDS Pilot Study manuscript
ID
NCT06654752
Study Type
Interventional
Participants
Expecting 430 study participants
Last Updated